Europe Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted , Perinatal Infections. STDs, Urinary Tract Infections, And Respiratory Tract Infections), By End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies)and By Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016–2021)

Europe Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted , Perinatal Infections. STDs, Urinary Tract Infections, And Respiratory Tract Infections), By End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies)and By Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016–2021)

ID: 5113 | Pages: 145 | December 2017 | Region: Europe


The Europe Virology Market is worth USD xx million in 2016 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2021. The Europe Virology market is developing at an exceptionally quick pace.

Virology refers to the study of viruses which are submicroscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents. It mainly focuses on their structure, classification and evolution, their ways to infect and exploit host cells for reproduction, their interaction with host organism physiology and immunity, the they cause, the techniques to isolate and culture them, and their use in research and therapy. Virology is generally considered as subfield of microbiology.

The significant drivers are various treatments and diagnostic processes that use virology application. Increasing applications of virology in gene therapy, phage therapy, formulation of vaccines etc. is also expected to boost the market. Increasing Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor driving the market. However quality and safety standards is a longstanding challenge, and stringent approval processes for antiviral drugs may limit the growth of this industry.

The Europe Virology market is segmented on the basis of Type, application, end user and region. Based on Type the market is segmented into Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons. Based on Application the market is segmented into Skin and Soft Tissue Infections, GI Tract Infections, Urinary Tract infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted, Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections. Based on end user the market is segmented into hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies. Hospitals and Clinics are largest segment which account for nearly 50% of the market share.

The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. Europe region had the highest CAGR owing to improved healthcare infrastructure, increasing access to diagnostics, and growing affordability of diagnostic tests for viral.

Boehringer Ingelheim Corporation, Merck and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche. are the some of the key players in the Europe Virology market.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Type                                                                              

                                5.1.1 Introduction                                                           

                                5.1.2 Diagnosing Test                                                     

                                                5.1.2.1 DNA Viruses                                       

                                                5.1.2.2 RNA Viruses                                        

                                                5.1.2.3 Prions Diagnostic Test                                     

                                                5.1.2.4 Other Viral Tests                                               

                                5.1.3 Viral Infection Controlling Methods                                                             

                                                5.1.3.1 Immunoprophylaxis                                        

                                                5.1.3.2 Active Prophylaxis (Vaccines)                                      

                                                5.1.3.3 Passive Prophylaxis                                         

                                5.1.4 Antiviral Chemotherapy                                                    

                                                5.1.4.1 Virucidal Agents                                

                                                5.1.4.2 Antiviral Agents                                 

                                                5.1.4.3 Immunomodulators                                        

                                5.1.5 Interferons                                                             

                                                5.1.5.1 Cytokines                                             

                                5.1.6 Y-o-Y Growth Analysis, By Type                                                     

                                5.1.7 Market Attractiveness Analysis, By Type                                                   

                                5.1.8 Market Share Analysis, By Type                                                     

                5.2 Application                                                                 

                                5.2.1 Introduction                                                           

                                5.2.2 Skin and Soft Tissue Infections                                                       

                                5.2.3 Respiratory Tract Infections                                                             

                                5.2.4 GI Tract Infections                                               

                                5.2.5 Urinary Tract Infections                                                     

                                5.2.6  Eye Infections                                                       

                                5.2.7 CNS Infections                                                       

                                5.2.8 Sexually Transmitted Diseases                                                       

                                5.2.9 Perinatal Infections                                                             

                                5.2.10 Y-o-Y Growth Analysis, By Application                                                      

                                5.2.11  Market Attractiveness Analysis, By Application                                                   

                                5.2.12  Market Share Analysis, By Application                                                     

                5.3 End User                                                                      

                                5.3.1 Introduction                                                           

                                5.3.2 Hospitals                                                  

                                5.3.3 Clinics                                                        

                                5.3.4 Laboratories                                                           

                                5.3.5 Diagnostic Centres                                                               

                                5.3.6 Blood Banks                                                            

                                5.3.7 Pharmacies                                                             

                                5.3.8 Y-o-Y Growth Analysis, By End User                                                             

                                5.3.9  Market Attractiveness Analysis, By End User                                                          

                                5.3.10  Market Share Analysis, By End User                                                         

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Type                                 

                                                6.1.3.3 By Application                                    

                                                6.1.3.4 By End User                                        

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Type                                 

                                                6.1.4.3 By Application                                    

                                                6.1.4.4 By End User                                        

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Type                                 

                                                6.1.5.3 By Application                                    

                                                6.1.5.4 By End User                                        

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Johnson & Johnson                                                                 

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Abbott Laboratories                                                               

                8.3 GlaxoSmithKline plc                                                                

                8.4 Boehringer Ingelheim Corporation                                                                   

                8.5 Merck and Co. Inc.                                                                  

                8.6 Novartis International AG                                      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Virology Market By Type, From 2016-2021 ( USD Million )
  2. Europe Diagnosing Test Market By Region, From 2016-2021 ( USD Million )
  3. Europe Viral Infection Controlling Methods Market By Region, From 2016-2021 ( USD Million )
  4. Europe Antiviral Chemotherapy Market By Region, From 2016-2021 ( USD Million )
  5. Europe Interferons Market By Region, From 2016-2021 ( USD Million )
  6. Europe Virology Market By Application, From 2016-2021 ( USD Million )
  7. Europe Respiratory Tract Infections Market By Region, From 2016-2021 ( USD Million )
  8. Europe GI Tract Infections Market By Region, From 2016-2021 ( USD Million )
  9. Europe Urinary Tract Infections Market By Region, From 2016-2021 ( USD Million )
  10. Europe Eye Infections Market By Region, From 2016-2021 ( USD Million )
  11. Europe CNS Infections Market By Region, From 2016-2021 ( USD Million )
  12. Europe Sexually Transmitted Diseases Market By Region, From 2016-2021 ( USD Million )
  13. Europe Perinatal Infections Market By Region, From 2016-2021 ( USD Million )
  14. Europe Virology Market By End User, From 2016-2021 ( USD Million )
  15. Europe Hospitals Market By Region, From 2016-2021 ( USD Million )
  16. Europe Clinics Market By Region, From 2016-2021 ( USD Million )
  17. Europe Laboratories Market By Region, From 2016-2021 ( USD Million )
  18. Europe Diagnostic Centres Market By Region, From 2016-2021 ( USD Million )
  19. Europe Blood Banks Market By Region, From 2016-2021 ( USD Million )
  20. Europe Pharmacies Market By Region, From 2016-2021 ( USD Million )
  21. U.K. Virology Market By Type, From 2016-2021 ( USD Million )
  22. U.K. Virology Market By Application, From 2016-2021 ( USD Million )
  23. U.K. Virology Market By End User, From 2016-2021 ( USD Million )
  24. Germany Virology Market By Type, From 2016-2021 ( USD Million )
  25. Germany Virology Market By Application, From 2016-2021 ( USD Million )
  26. Germany Virology Market By End User, From 2016-2021 ( USD Million )
  27. France Virology Market By Type, From 2016-2021 ( USD Million )
  28. France Virology Market By Application, From 2016-2021 ( USD Million )
  29. France Virology Market By End User, From 2016-2021 ( USD Million )
  30. Italy Virology Market By Type, From 2016-2021 ( USD Million )
  31. Italy Virology Market By Application, From 2016-2021 ( USD Million )
  32. Italy Virology Market By End User, From 2016-2021 ( USD Million )
  33. Spain Virology Market By Type, From 2016-2021 ( USD Million )
  34. Spain Virology Market By Application, From 2016-2021 ( USD Million )
  35. Spain Virology Market By End User, From 2016-2021 ( USD Million )
Middle East And Africa Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinar...
Latin America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Asia Pacific Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract In...
Europe Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infectio...
North America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye ...
Middle East And Africa Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competi...
Latin America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Asia Pacific Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mult...
Europe Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex,...
North America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwi...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.